A new American medicine against cancer

The US Food and Drug Administration (FDA) has approved a new drug for the treatment of adult and pediatric cancer patients based on genetic mutations rather than the type of disease.

The medicine Vitrakvi and the scientific name LAROTECTINIB are approved for the treatment of cancers that occur throughout the body.

NITCAVI is the first drug designed from the beginning to combat the genetic mutation of the disease, regardless of the type of cancer, according to NBC.

FDA approval is an important step in the treatment of cancer, "said FDA Commissioner Scott Gottlieb in a statement. The basis of tumor genes, regardless of where they originate in the body. "

"This will help patients get" timely treatment, "he said.

He said that the drug treats people with different tumors but has a common genetic mutation, noting that this was not available ten years ago because knowledge about genetic mutations was then less than now.

Source link